Hossein Amirkhani

The promise of deep urine proteomics for diagnosis of cancer, neurologic, and metabolic diseases

Urine proteomics identified disease‑related signals across cancer and metabolic conditions and may enable accurate, noninvasive classification using multiprotein panels, but given the exploratory design and its limitations, the reported accuracies should be regarded as upper-bound estimates requiring prospective valida...